Literature DB >> 3977975

Quantitation of the Sm nuclear antigen in tissues and activated lymphocytes.

C M Boyer, R A Eisenberg, P L Cohen.   

Abstract

Anti-Sm antibodies are specific for the diagnosis of systemic lupus erythematosus both in humans and in mice. Because the autoantibody response to this nuclear ribonucleoprotein particle is probably antigen driven, we have quantitated the Sm antigen in cells and tissues, using a highly sensitive and specific enzyme-linked immunosorbent assay. The Sm content of several in vitro cell lines was determined to be approximately 1 pg of Sm/cell. We found that murine spleen cells stimulated in vitro with either T cell or B cell mitogens contained up to 10 times more Sm than did unstimulated cells and that they also released increased amounts of Sm. In a survey of organs from several mouse strains, we found that lymphoid tissues had the largest amounts of Sm and that the Sm content of a particular tissue correlated with its DNA content. Increased amounts of Sm in and around activated lymphocytes, as found in systemic lupus erythematosus, may provide a source of antigen for the induction of the anti-Sm autoantibody.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977975     DOI: 10.1002/art.1780280309

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

Review 1.  Anti-Sm autoantibodies in systemic lupus erythematosus mice: a model system for disease-specific autoreactivity.

Authors:  R A Eisenberg
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Heterogeneity of RNP and Sm autoantigens in relation to the cell sources and the activated state of the cells.

Authors:  F Hiepe; K Yamamoto; A Takeuchi; E Apostoloff; T Miyamoto
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

3.  The Epstein-Barr virus and systemic lupus erythematosus.

Authors:  J H Vaughan
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

4.  Nuclear antigens in neoplastic lymphocytes of B cell and T cell non-Hodgkin's lymphomas.

Authors:  I Dardick; R Hall; D J Bailey; M Stratis; D L Brown; N Chaly
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

5.  Antibody penetration of viable human cells. II. Anti-RNP antibodies binding to RNP antigen expressed on cell surface, which may mediate the antibody internalization.

Authors:  J Ma; N King; S L Chen; R Penny; S N Breit
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

6.  Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.

Authors:  R A Eisenberg; S Y Craven; R W Warren; P L Cohen
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

Review 7.  Studies of murine systemic autoimmunity.

Authors:  Philip L Cohen
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

8.  RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

Authors:  Christina M Lau; Courtney Broughton; Abigail S Tabor; Shizuo Akira; Richard A Flavell; Mark J Mamula; Sean R Christensen; Mark J Shlomchik; Gregory A Viglianti; Ian R Rifkin; Ann Marshak-Rothstein
Journal:  J Exp Med       Date:  2005-10-31       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.